Researchers from the University of Nottingham have joined forces with biotechnology company HydRegen for a project that will unlock sustainable biocatalytic hydrogenation – allowing the process to be scaled up and improved for industry use.
New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them more vulnerable to a severe infection.